CD4 and non-small cell lung carcinoma: Our results revealed remarkable systemic immune dysregulation in early NSCLC characterized by a reduction in total lymphocytes, CD3+ T cells, HLA-DR− CD3+ T cells, CD4+ T cells, and NKT cells.